The novel therapy of the medication represents a significant advance in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide affects two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide978674.anchor-blog.com/22480050/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment